Nintedanib, a triple tyrosine kinase inhibitor, attenuates renal fibrosis in chronic kidney disease

Feng Liu, Li Wang, Hualin Qi, +6

Clinical Science

Antifibrotic TherapyLung InflammationRenal PathologyRenal InflammationPathology +22

RETRACTED ARTICLE: Silencing of Histone Deacetylase 9 Expression in Podocytes Attenuates Kidney Injury in Diabetic Nephropathy

Feng Liu, Ming Zong, Xiaofei Wen, +7

Scientific Reports

Elevated Serum IL-39 in Patients With ST-segment Elevation Myocardial Infarction was Related with Left Ventricular Systolic Dysfunction

Yu Luo, Feng Liu, Huadong Liu, +4

Biomarkers in Medicine

Synergistic Inhibition of Renal Fibrosis by Nintedanib and Gefitinib in a Murine Model of Obstructive Nephropathy

Feng Liu, Wang Li, Yu Chao, +7

Kidney Diseases

Requirement of Histone Deacetylase 6 for Interleukin-6 Induced Epithelial-Mesenchymal Transition, Proliferation, and Migration of Peritoneal Mesothelial Cells

Yingfeng Shi, Min Tao, Jun Ni, +9

Frontiers in Pharmacology

Nintedanib attenuates peritoneal fibrosis by inhibiting mesothelial‐to‐mesenchymal transition, inflammation and angiogenesis

Feng Liu, Chao Yu, Huan Qin, +8

Journal of Cellular and Molecular Medicine

Critical roles of SMYD2 lysine methyltransferase in mediating renal fibroblast activation and kidney fibrosis

Lirong Liu, Feng Liu, Yingjie Guan, +7

The FASEB Journal

Renal PathologyRenal InflammationPathologyProtein 2Renal Fibroblast Activation +19

Association Between Extent of Stent-Graft Coverage and Thoracic Aortic Remodeling After Endovascular Repair of Type B Aortic Dissection

Yan Xue, Yangyang Ge, Xiaohu Ge, +6

Journal of Endovascular Therapy

Targeting Src attenuates peritoneal fibrosis and inhibits the epithelial to mesenchymal transition

Jun Wang, Li Wang, Liuqing Xu, +5

Oncotarget

Correlation of Serum Adropin Levels with Risk Factors of Cardiovascular Disease in Hemodialysis Patients

Feng Liu, Binbin Cui, Xinhui Zhao, +13

Metabolic Syndrome and Related Disorders